A preparation and a collection procedure
Bone marrow aspirate concentrate is a preparation made from a person’s own bone marrow, containing cells and growth factors. Clinics may offer it as an injection; confirm the proposed collection, preparation, and use. Bone marrow aspiration names the collection procedure. Bone marrow aspirate names the collected material. BMAC refers to a concentrate prepared from it.
Keep those three labels separate in your written notes. Ask the clinician to describe the collection procedure on one line and the final preparation on another. Then record where and how the preparation would be used. If the clinic provides a single package name, request the details needed to understand each step and the person responsible for it.
- Shapiro et al. Placebo-controlled BMAC trial (2017); abstract · American Journal of Sports Medicine via PubMed
- Orthobiologics (Regenerative Medicine) FAQ · AAOS OrthoInfo
Clarify what “cells” means in this offer
Ask the clinic to identify the actual material and any additional substances. A broad term such as “stem cell treatment” is not a complete product description. If a clinic cites a study, confirm whether the study tested marrow concentrate, a different tissue source, or cells prepared by another method.
The MILES trial treated marrow concentrate, adipose stromal vascular fraction, and umbilical-cord-derived stromal cells as distinct interventions. Combining their names into one advertising category would lose information necessary to understand the comparison.
- Where would the material come from, and is it from me or a donor?
- What processing, storage, mixing, or additional materials are proposed?
- What measurements describe the final preparation, and what do those measurements establish?
- Which paper studies that preparation for the same diagnosis and intended use?
- Mautner et al. Cell-based versus corticosteroid injections (2023); abstract and disclosures · Nature Medicine via PubMed
- MILES trial author correction (2024) · Nature Medicine via PubMed
Assess the whole procedure
A consultation should address both obtaining the material and using it. Ask who is responsible for each step, where each step occurs, and what monitoring is planned. Request an explanation of pain control, collection-site care, injection-site care, and how the clinic handles unexpected problems.
Have the clinician explain risks in relation to your health history and other care. A statement that a material comes from your own body does not answer every safety question. Ask for written instructions and a contact plan that identifies whom to call, what information to provide, and what to do when the office is closed.
Keep evidence tied to the proposed outcome
For knee osteoarthritis, the studies summarized in our evidence brief use different comparators and preparations. A change after an injection is not the same measurement as a difference between randomized groups. Ask whether a claimed benefit concerns pain, daily function, imaging findings, or avoiding another procedure, and whether the cited study actually measured that outcome.
Keep claims about tissue repair separate from reports of symptom improvement. Ask to see the relevant results rather than relying on a product name, a diagram of cells, or an account of an individual patient. The brief provides examples for that discussion; it does not determine whether BMAC is appropriate for you.
- Shapiro et al. Placebo-controlled BMAC trial (2017); abstract · American Journal of Sports Medicine via PubMed
- Han et al. BMAC injections: systematic review of randomized trials (2024); abstract · Orthopaedic Journal of Sports Medicine via PubMed
Make the decision and estimate reviewable
Request a written proposal that separates evaluation, collection, preparation, administration, imaging, and follow-up. Note which charges are fixed, which are estimates, and what may be billed by another provider. Ask how the plan changes if you need more evaluation or if you choose another option.
For a regulatory claim, record the exact product, intended use, and official reference supplied by the clinic. Ask the clinician to explain how that reference applies to your proposal. The directory’s BMAC category is a way to find reported services; it does not establish the regulatory status or effectiveness of a specific procedure.
Questions to bring
- What exactly would be collected, processed, and administered?
- What evidence supports this preparation for the outcome we are discussing?
- How are collection, administration, and follow-up risks and charges addressed?
Sources and editorial context
This reference was compiled from the sources below and has not received independent clinical review. Use it to understand terms and prepare questions for a qualified professional who can consider your circumstances.
- Orthobiologics (Regenerative Medicine) FAQ · AAOS OrthoInfoReference checked 2026-10-02
- Shapiro et al. Placebo-controlled BMAC trial (2017); abstract · American Journal of Sports Medicine via PubMedReference checked 2026-10-02
- Mautner et al. Cell-based versus corticosteroid injections (2023); abstract and disclosures · Nature Medicine via PubMedReference checked 2026-10-02
- MILES trial author correction (2024) · Nature Medicine via PubMedReference checked 2026-10-02
- Han et al. BMAC injections: systematic review of randomized trials (2024); abstract · Orthopaedic Journal of Sports Medicine via PubMedReference checked 2026-10-02